Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model

Rockx, Barry, Kuiken, Thijs, Herfst, Sander, Bestebroer, Theo, Lamers, Mart M., Oude Munnink, Bas B., de Meulder, Dennis, van Amerongen, Geert +16 more·2020·Science
DOI 10.1126/science.abb7314

Cited by (878)

Items 201–300 of 878

  1. Perspective: The Potential Effects of Naringenin in COVID-19
    Ricardo Wesley Alberca, Franciane Mouradian Emidio Teixeira, Danielle Rosa Beserra, Emily Araujo de Oliveira, Milena Mary de Souza Andrade, Anna Julia Pietrobon, Maria Notomi Sato · 2020 · Frontiers in Immunology
  2. Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure
    Sara C. Johnston, Keersten Michelle Ricks, Alexandra N. Jay, Jo Lynne Raymond, Franco Rossi, Xiankun Zeng, Jennifer L. Scruggs, David N. Dyer, Ondraya M. Frick, Jeffrey W. Koehler et al. · 2021 · PLoS ONE
  3. Spike protein mediated membrane fusion during SARS‐CoV‐2 infection
    Xinyu Li, Huijun Yuan, Xiaozhen Li, Hongliang Wang · 2022 · Journal of Medical Virology
  4. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
    Calvin Andeve Omolo, Nikki Soni, Victoria Oluwaseun Fasiku, Irene Mackraj, Thirumala Govender · 2020 · European Journal of Pharmacology
  5. A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
    Sabari Nath Neerukonda, Upendra Katneni · 2020 · Pathogens
  6. Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses
    Ria R. Ghai, Ann Carpenter, Meghan Herring, Krystalyn B. Martin, Susan I. Gerber, Aron Hall, Amanda Liew, Jonathan Mark Sleeman, Sophie VonDobschuetz, Casey Barton Behravesh · 2021 · Emerging infectious diseases
  7. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
    Chuan Xu, Annie Wang, M. Marin, W. Honnen, Santhamani Ramasamy, E. Porter, S. Subbian, A. Pinter, G. Melikyan, Wu-Yuan Lu et al. · 2021 · Viruses
  8. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase
    Robert W. Cross, Krystle N. Agans, Abhishek N. Prasad, Viktoriya Borisevich, Courtney B. Woolsey, Daniel J. Deer, Natalie S. Dobias, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert · 2020 · Virology Journal
  9. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection
    Helen Everett, Fabian Z. X. Lean, Alexander M. P. Byrne, Pauline M. van Diemen, Shelley G. Rhodes, Joe James, Benjamin C. Mollett, Vivien J. Coward, Paul Skinner, Caroline J. Warren et al. · 2021 · Viruses
  10. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond
    Anthony R. Sciaudone, Heather A. Corkrey, Fiachra Humphries, Milka Koupenova · 2023 · Circulation Research
  11. The human–primate interface in the New Normal: Challenges and opportunities for primatologists in the COVID‐19 era and beyond
    Susan Lappan, Suchinda Malaivijitnond, S. Radhakrishna, Erin P. Riley, Nadine Ruppert · 2020 · American Journal of Primatology
  12. Animal models for SARS-CoV-2
    Chung-Young Lee, Anice C. Lowen · 2021 · Current Opinion in Virology
  13. Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing
    Elizabeth Varghese, Samson Mathews Samuel, Alena Líšková, Peter Kubatka, Dietrich Büsselberg · 2021 · PLoS Pathogens
  14. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
    Hosoki, Koa, Chakraborty, Abhijit, Sur, Sanjiv · 2020 · Journal of Allergy and Clinical Immunology
  15. COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2
    Ling Xu, 中国科学院昆明动物研究所，动物模型与人类疾病机理重点实验室，KIZ-CUHK生物资源与疾病分子机理联合实验室，云南 昆明 650223，中国, Dandan Yu, Yuhua Ma, Yulin Yao, Rong-Hua Luo, Xiao-Li Feng, Hourong Cai, Jian-Bao Han, Xuehui Wang et al. · 2020 · 动物学研究
  16. SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives
    Samuel Long · 2021 · Viruses
  17. Pathophysiology of infection with SARS‐CoV ‐2— What is known and what remains a mystery
    Siddharth Sridhar, John Malcolm Nicholls · 2021 · Respirology
  18. Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2
    Iryna V. Goraichuk, Vasiliy L. Arefiev, B. Т. Stegniy, Anton Gerilovych · 2021 · Virus Research
  19. Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
    Philip L. Tzou, Kaiming Tao, Janin Nouhin, Soo‐Yon Rhee, Benjamin D Hu, Shruti Pai, Neil T. Parkin, Robert W. Shafer · 2020 · Viruses
  20. SARS-CoV-2 and influenza: a comparative overview and treatment implications
    Laura D. Manzanares, Oscar Medina Contreras · 2020 · Boletín Médico del Hospital Infantil de México
  21. Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates
    Zhao, Hui, Wang, Tie-Cheng, Li, Xiao-Feng, Zhang, Na-Na, Li, Liang, Zhou, Chao, Deng, Yong-Qiang, Cao, Tian-Shu, Yang, Guan, Li, Rui-Ting et al. · 2021 · Signal Transduction and Targeted Therapy
  22. Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
    Cedric C.S. Tan, Su Datt Lam, Damien Richard, Christopher J. Owen, Dorothea Berchtold, Christine Anne Orengo, Meera Surendran Nair, Suresh Varma Kuchipudi, Vivek Kapur, Lucy van Dorp et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
    Zhaoyong Zhang, Eric Zeng, Lu Zhang, Weiming Wang, Yingkang Jin, Jiye Sun, Shuxiang Huang, Wenguang Yin, Jun Dai, Zhen Zhuang et al. · 2021 · Cell Discovery
  24. COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases
    Silvana Valdebenito, Simon Bessis, Djillali Annane, Geoffroy Lorin de la Grandmaison, Elisabeth Martin Cramer, Brendan Prideaux, Eliseo A. Eugenín, Morgane Bomsel · 2021 · Frontiers in Immunology
  25. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
    Enríc Vidal, Carlos López-Figueroa, Jordi Rodon, Mónica Pérez, Marco Brustolin, Guillermo Cantero, Vı́ctor Guallar, Nuria Izquierdo‐Useros, Jorge Carrillo, Julià Blanco et al. · 2021 · Veterinary Pathology
  26. Preparing for outbreaks – Implications for resilient water utility operations and services
    Veera Gnaneswar Gude, Preeti Judith Muire · 2020 · Sustainable Cities and Society
  27. Natural Infection by SARS-CoV-2 in Companion Animals: A Review of Case Reports and Current Evidence of Their Role in the Epidemiology of COVID-19
    Hélio Autran de Morais, Andrea Pires dos Santos, Naíla Cannes do Nascimento, Louise Bach Kmetiuk, David Soeiro Barbosa, Paulo Eduardo Brandão, Ana M. S. Guimarães, Christina Pettan-Brewer, Alexander Welker Biondo · 2020 · Frontiers in Veterinary Science
  28. Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2
    Élodie Monchâtre-Leroy, Sandrine Lesellier, Marine Wasniewski, Evelyne Picard Meyer, Céline Richomme, Franck Boué, Sandra Lacôte, Séverine Murri, Coralie Pulido, Johann Vulin et al. · 2021 · Journal of General Virology
  29. Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection
    Ya-Kun Liu, Tania M Garron, Q. Chang, Zhengchen Su, Changcheng Zhou, Yuan Qiu, Eric C. Gong, Jun-Ying Zheng, Y. Yin, T. Ksiazek et al. · 2021 · Pathogens
  30. Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges
    Jing Yang, Yuhuan Gong, Chunge Zhang, Ju Sun, Gary Wong, Weifeng Shi, Wenjun Liu, George F. Gao, Yuhai Bi · 2022 · The Innovation
  31. SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control
    no-firstname EFSA Panel on Animal Health and Welfare, Søren Saxmose Nielsen, Julio Álvarez, Dominique Bicout, Paolo Calistri, Elisabetta Canali, Julian Ashley Drewe, Bruno Garin‐Bastuji, José L. Gonzáles, Christian Gortázar et al. · 2023 · EFSA Journal
  32. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling
    J. S. Bednash, V. Kagan, J. Englert, D. Farkas, Y. Tyurina, V. Tyurin, S. Samovich, L. Farkas, Ajit Elhance, F. Johns et al. · 2021 · Translational Research: The Journal of Laboratory and Clinical Medicine
  33. Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies
    Júlia Vergara‐Alert, Jordi Rodon, Jorge Carrillo, Nigeer Te, Nuria Izquierdo‐Useros, Maria Luisa Rodrı́guez de la Concepción, Carlos Ávila‐Nieto, Vı́ctor Guallar, Alfonso Valencia, Guillermo Cantero et al. · 2020 · Transboundary and Emerging Diseases
  34. COVID‐19, cilia, and smell
    Wei Li, Ming Li, Guangshuo Ou · 2020 · FEBS Journal
  35. Cell and animal models of SARS-CoV-2 pathogenesis and immunity
    Sarah R. Leist, Alexandra Schäfer, David R. Martinez · 2020 · Disease Models & Mechanisms
  36. Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?
    Beatriz do Vale, Ana Patrícia Lopes, Maria da Conceição Fontes, A.M. Silvestre, Luı́s Cardoso, Ana Cláudia Coelho · 2021 · Veterinary Research Communications
  37. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients
    Yasuo Okada, Ken Yoshimura, Shuji Toya, Makoto Tsuchimochi · 2021 · Japanese Dental Science Review
  38. Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung
    Ting-Hsuan Wu, Kyle J. Travaglini, Arjun Rustagi, Duo Xu, Yue Zhang, Leonid P. Andronov, SoRi Jang, Astrid Gillich, Roozbeh Dehghannasiri, Giovanny J. Martínez-Colón et al. · 2024 · The Journal of Experimental Medicine
  39. Nanotraps for the containment and clearance of SARS-CoV-2
    Min Chen, Jillian Rosenberg, Xiaolei Cai, A. Lee, Jiu-Yun Shi, Mindy Nguyen, T. Wignakumar, Vikranth R. Mirle, Arianna Edobor, John F. Fung et al. · 2021 · bioRxiv
  40. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area
    Mazin Adnan Barry, Abdulellah Musaid Almohaya, Ali Alhijji, Layan Akkielah, Abdulaziz AlRajhi, Fahad M. Almajid, Aynaa Alsharidi, Fatimah Saad Alshahrani, Naif H. Alotaibi, Awadh Alanazi et al. · 2020 · Journal of Epidemiology and Global Health
  41. Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
    Michele Carbone, John A. Lednicky, Shu‐Yuan Xiao, Mario Venditti, Enrico M Bucci · 2021 · Journal of Thoracic Oncology
  42. Protection From COVID-19: The Efficacy of Face Masks
    Christoph Josef Hemmer, Frank T. Hufert, Stefan Siewert, Emil Christian Reisinger · 2021 · Deutsches Ärzteblatt international
  43. Insights into SARS-CoV-2 Persistence and Its Relevance
    Belete Ayele Desimmie, Yonas Raru, Hesham Awadh, Peimei He, Samson Teka, Kara S. Willenburg · 2021 · Viruses
  44. Susceptibility of Pets to SARS-CoV-2 Infection: Lessons from a Seroepidemiologic Survey of Cats and Dogs in Portugal
    Ricardo Alexandre Barroso, Alexandre Vieira-Pires, Agostinho Antunes, Isabel Fidalgo-Carvalho · 2022 · Microorganisms
  45. Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
    Young‐Il Kim, Kwang-Min Yu, June‐Young Koh, Eun-Ha Kim, Se‐Mi Kim, Eun Ji Kim, Mark Anthony B. Casel, Rare Rollon, Seung‐Gyu Jang, Min‐Suk Song et al. · 2022 · Nature Communications
  46. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement
    K. Stenmark, M. Frid, E. Gerasimovskaya, Hui Zhang, M. McCarthy, J. Thurman, T. Morrison · 2021 · Pulmonary Circulation
  47. Investigation on visible-light photocatalytic performance and mechanism of zinc peroxide for tetracycline degradation and Escherichia coli inactivation
    Pei Chen, Ningning Dong, Junjie Zhang, Wei Wang, Fatang Tan, Xinyun Wang, Xueliang Qiao, Po Keung Wong · 2022 · Journal of Colloid and Interface Science
  48. Engineering a Model to Study Viral Infections: Bioprinting, Microfluidics, and Organoids to Defeat Coronavirus Disease 2019 (COVID-19)
    Anastasia I. Shpichka, Polina Bikmulina, Maria Peshkova, Nastasia V. Kosheleva, Зурина Ирина Михайловна, Ensieh Zahmatkesh, Niloofar Khoshdel Rad, Marina Lipina, Е. Н. Голубева, Denis V. Butnaru et al. · 2020 · International Journal of Bioprinting
  49. Transmission and prevention of SARS-CoV-2
    Zhongyi Wang, Yingying Fu, Zhendong Guo, Jiaming Li, Jing Li, Hongliang Cheng, Bing Lu, Qiang Sun · 2020 · Biochemical Society Transactions
  50. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
    Mirjam Kiener, Nuria Roldán, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier T. Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof‐de Julio · 2021 · Frontiers in Medicine
  51. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus
    C. T. Ekanger, Fan Zhou, Dana Bohan, Maria L. Lotsberg, M. Ramnefjell, L. Hoareau, G. Røsland, Ning Lu, M. Aanerud, F. Gärtner et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  52. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID‐19
    Brittany H. Bodnar, Kena Patel, Wen‐Zhe Ho, Jin Jun Luo, Wenhui Hu · 2020 · Journal of Medical Virology
  53. The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues
    K. Böszörményi, M. Stammes, Zahra C. Fagrouch, Gwendoline Kiemenyi-Kayere, H. Niphuis, D. Mortier, N. van Driel, I. Nieuwenhuis, R. Vervenne, T. Haaksma et al. · 2020 · Viruses
  54. Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
    Bijayeeta Deb, Hemal Shah, Suchi Goel · 2020 · Journal of Biosciences
  55. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
    M. Brustolin, J. Rodón, M. L. Rodríguez de la Concepción, C. Ávila-Nieto, G. Cantero, M. Pérez, Nigeer Te, M. Noguera-Julián, V. Guallar, Alfonso Valencia et al. · 2021 · Emerging Microbes and Infections
  56. The potential of electrochemistry for the detection of coronavirus-induced infections
    Rachel Rui Xia Lim, Alessandra Bonanni · 2020 · TrAC Trends in Analytical Chemistry
  57. Postulated Adjuvant Therapeutic Strategies for COVID-19
    Anderson Oliveira Ferreira, Hudson Caetano Polonini, Eli C. F. Dijkers · 2020 · Journal of Personalized Medicine
  58. A Biosafety Level 2 Mouse Model for Studying Betacoronavirus-Induced Acute Lung Damage and Systemic Manifestations
    Ana Cláudia dos Santos Pereira Andrade, Gabriel Henrique Campolina-Silva, Celso Martins Queiroz‐Junior, Leonardo Camilo de Oliveira, Larisse de Souza Barbosa Lacerda, Jordane Clarisse Pimenta, Filipe Resende, Ian de Meira Chaves, Ingredy Beatriz Souza Passos, Danielle Cunha Teixeira et al. · 2021 · Journal of Virology
  59. Kinetics of SARS-CoV-2 infection in the human upper and lower respiratory tracts and their relationship with infectiousness
    Ruian Ke, Carolin Zitzmann, Ruy Miguel Ribeiro, Alan S. Perelson · 2020 · medRxiv
  60. Aerosol transmission, an indispensable route of COVID-19 spread: case study of a department-store cluster
    Guanyu Jiang, Can Wang, Lu Song, Xing Wang, Yangyang Zhou, Chunnan Fei, He Liu · 2020 · Frontiers of Environmental Science & Engineering
  61. An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies
    Tahmeena Farooqi, Jonaid Ahmad Malik, Almas Hanif Mulla, Turki Al Hagbani, Khaled Almansour, Mohammed Abrar Ubaid, Saleh Alghamdi, Sirajudheen Anwar · 2021 · Journal of Infection and Public Health
  62. An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Alejandro Pascual‐Iglesias, Javier Cantón, Ana Maria Ortega‐Prieto, Jose M. Jiménez-Guardeño, José Ángel Regla-Nava · 2021 · Pathogens
  63. Early Insights into Immune Responses during COVID-19
    Ashley L. St. John, Abhay P. S. Rathore · 2020 · The Journal of Immunology
  64. Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
    Yaqing Wang, Peng Wang, Jianhua Qin · 2022 · Advanced Science
  65. On the road to ending the COVID-19 pandemic: Are we there yet?
    J. Case, Emma S. Winkler, J. Errico, Michael S. Diamond · 2021 · Virology
  66. Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
    Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, S. Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, S. Aoki, Kouji Kuramochi et al. · 2021 · Frontiers in Microbiology
  67. Interleukin-1RA Mitigates SARS-CoV-2–Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice
    Shiqin Xiong, Lianghui Zhang, Abdul S. Qadir, Justin M. Richner, Jacob Class, Jalees Rehman, Asrar B. Malik · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  68. Experimental Models of COVID-19
    Luis A. Caldera-Crespo, Michael John Paidas, Sabita Roy, Carl Ivan Schulman, Norma Sue Kenyon, Sylvia Daunert, Arumugam Radhakrishnan Jayakumar · 2022 · Frontiers in Cellular and Infection Microbiology
  69. Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns
    Jigarji Chaturji Thakor, M. Dinesh, Rajendran Manikandan, Suresh Bindu, Monalisa Sahoo, Diptimayee Sahoo, Manish K. Dhawan, Megha Katare Pandey, Ruchi Tiwari, Talha Bin Emran et al. · 2022 · Veterinary Quarterly
  70. Heterogeneous groups of alveolar type II cells in lung homeostasis and repair
    Qian Chen, Yuru Liu · 2020 · American Journal of Physiology-Cell Physiology
  71. ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and Therapeutics
    J. A. Hewitt, C. Lutz, William C. Florence, M. L. Pitt, Srinivas Rao, Jay Rappaport, N. Haigwood · 2020 · Cell Host and Microbe
  72. Myeloid cell interferon responses correlate with clearance of SARS-CoV-2
    D. Singh, E. Aladyeva, Shibali Das, Bindu Singh, E. Esaulova, A. Swain, Mushtaq Ahmed, Journey Cole, Chivonne Moodley, S. Mehra et al. · 2022 · Nature Communications
  73. Endocrine Conditions and COVID-19
    Skand Shekhar, Rachel Wurth, Crystal Dawn Chrysavgi Kamilaris, Graeme Eisenhofer, Francisco J. Barrera, Michelle Hajdenberg, Joselyne Tessa Tonleu, Janet Elizabeth Hall, Ernesto L. Schiffrin, Forbes D. Porter et al. · 2020 · Hormone and Metabolic Research
  74. Non-human primate models of human respiratory infections
    Julien Lemaître, Thibaut Naninck, Benoît Delache, Justina Creppy, Philippe Huber, Marion Holzapfel, Camille Bouillier, Vanessa Contreras, Frédéric Martinon, Nidhal Kahlaoui et al. · 2021 · Molecular Immunology
  75. Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium
    Kaixin Liang, Katherine Camille Barnett, Martin Hsu, Wei-Chun Chou, Sachendra S. Bais, Kristina J. Riebe, Yuying Xie, Tuong Thien Nguyen, Thomas H. Oguin, Kevin M. Vannella et al. · 2024 · Science Immunology
  76. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
    Kenneth S. Plante, Varun Dwivedi, Jessica A. Plante, Diana M Fernandez, Divya Mirchandani, Nathen E. Bopp, Patricia V. Aguilar, Jun-Gyu Park, Paula Pino Tamayo, Jennifer A. Delgado et al. · 2021 · Biomedicine & Pharmacotherapy
  77. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
    Olivier Terrier, Sébastien Dilly, Andrés Pizzorno, Dominika Chalupská, Jana Humpolíčková, Evžen Bouřa, Françis Berenbaum, Stéphane Quideau, Bruno Lina, Bruno Fève et al. · 2021 · Molecules
  78. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
    Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani, Roohangiz Nashibi, Sheyda Houshmandfar, Sima Tahmaseby Gandomkari, Ali Khodadadi · 2021 · Immunopharmacology and Immunotoxicology
  79. Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: A systematic review
    Adriano Aquino, Vânia Margaret Flosi Paschoalin, Letícia Tessaro, Paulo A. Raymundo‐Pereira, Carlos Adam Conte‐Júnior · 2022 · Journal of Pharmaceutical and Biomedical Analysis
  80. Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
    Corbett, Kizzmekia S., Nason, Martha C., Flach, Britta, Gagne, Matthew, O’ Connell, Sarah, Johnston, Timothy S., Shah, Shruti N., Edara, Venkata Viswanadh, Floyd, Katharine, Lai, Lilin et al. · 2021
  81. Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19
    Anna A. Valyaeva, Anastasia A. Zharikova, Artem S. Kasianov, Yegor S Vassetzky, Eugene V. Sheval · 2020 · Scientific Reports
  82. Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19
    Feihu Yan, Entao Li, Tiecheng Wang, Yuanguo Li, Jun Liu, Weiqi Wang, Tian Qin, Rina Su, Hongyan Pei, Shen Wang et al. · 2022 · Frontiers in Immunology
  83. Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research
    Khan Sharun, Ruchi Tiwari, Shailesh Kumar Patel, Kumaragurubaran Karthik, Mohd. Iqbal Yatoo, Yashpal Singh Malik, Karam Pal Singh, Parmod Kumar Panwar, Harapan Harapan, Raj Kumar Singh et al. · 2020 · Human Vaccines & Immunotherapeutics
  84. Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
    Christian Albert Devaux, Lucile Pinault, Ikram Omar Osman, Didier Raoult · 2021 · Frontiers in Public Health
  85. Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface
    Hayden D. Hedman, Eric Krawczyk, Yosra A. Helmy, Lixin Zhang, Csaba Varga · 2021 · Pathogens
  86. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model
    Bart L. Haagmans, Danny Noack, Nisreen M.A. Okba, Wentao Li, Chunyan Wang, Theo M. Bestebroer, Rory D. de Vries, Sander Herfst, Dennis de Meulder, Elwin P. Verveer et al. · 2021 · The Journal of Infectious Diseases
  87. Characteristic and quantifiable COVID-19-like abnormalities in CT- and PET/CT-imaged lungs of SARS-CoV-2-infected crab-eating macaques ( Macaca fascicularis )
    Courtney L. Finch, Ian Crozier, Ji Hyun Lee, Russ Byrum, Timothy K. Cooper, Janie Y. Liang, Kaleb Sharer, Jeffrey M. Solomon, Philip J. Sayre, Gregory A. Kocher et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  88. SARS-CoV-2 Rapidly Adapts in Aged BALB/c Mice and Induces Typical Pneumonia
    Yu-Fei Zhang, Kun Huang, Ting Wang, F. Deng, Wenxiao Gong, Xian-Feng Hui, Ya Zhao, Xinlin He, Chengfei Li, Qiang Zhang et al. · 2021 · Journal of Virology
  89. Increased airborne transmission of COVID-19 with new variants, Implications for health policies
    Bertrand R. Rowe, André Canosa, Amina Meslem, Frantz Rowe · 2022 · Building and Environment
  90. SARS-CoV-2 in animals: From potential hosts to animal models
    Anna Michelitsch, K. Wernike, Lorenz Ulrich, T. Mettenleiter, M. Beer · 2021 · Advances in Virus Research
  91. Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets
    Max Maurin, Florence Fenollar, Oleg Mediannikov, Bernard Davoust, Christian Albert Devaux, Didier Raoult · 2021 · Microorganisms
  92. COVID-19 cynomolgus macaque model reflecting human COVID-19 pathological conditions
    E. Urano, T. Okamura, Chikako Ono, Shiori Ueno, S. Nagata, H. Kamada, Mahoko Higuchi, Mugi Furukawa, W. Kamitani, Y. Matsuura et al. · 2021 · Proceedings of the National Academy of Sciences of the United States of America
  93. Ferrets are valuable models for SARS-CoV-2 research
    Małgorzata Ciurkiewicz, Federico Armando, Tom Schreiner, Nicole de Buhr, Veronika Pilchová, Vanessa Krupp-Buzimikic, Gülşah Gabriel, Maren von Köckritz‐Blickwede, Wolfgang Baumgärtner, Claudia Schulz et al. · 2022 · Veterinary Pathology
  94. Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19
    Tanja Paul, Stephan Ledderose, Harald S. Bartsch, Na Sun, Sarah Hamdy Soliman, Bruno Märkl, Viktoria Ruf, Jochen Wolfgang Herms, Marcel Stern, Oliver Till Keppler et al. · 2022 · Nature Communications
  95. Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution
    Christian Albert Devaux, Lucile Pinault, Jérémy Delerce, Didier Raoult, Anthony Levasseur, Roger Frutos · 2021 · Frontiers in Microbiology
  96. Interstitial pneumonia and diffuse alveolar damage in domestic animals
    Francisco R. Carvallo, Valentina B. Stevenson · 2022 · Veterinary Pathology
  97. Attenuated activation of pulmonary immune cells in mRNA-1273–vaccinated hamsters after SARS-CoV-2 infection
    Michelle Meyer, Yuan Wang, Darin K. Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, Chad E. Mire, Colette A. Pietzsch, Xi Chen, Yongchao Ge et al. · 2021 · Journal of Clinical Investigation
  98. Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination
    Serafeim C. Chaintoutis, Zoi Thomou, Evangelia Mouchtaropoulou, George Tsiolas, Taxiarchis Chassalevris, Ioanna Stylianaki, Maria K. Lagou, Sofia Michailidou, Evangelia Moutou, Jacobus Johannes Hendrik Koenen et al. · 2021 · PLoS Pathogens
  99. Function of epithelial stem cell in the repair of alveolar injury
    Manwai Chan, Yuru Liu · 2022 · Stem Cell Research & Therapy
  100. Cross-Species Transmission of Coronaviruses in Humans and Domestic Mammals, What Are the Ecological Mechanisms Driving Transmission, Spillover, and Disease Emergence?
    Nicole Nova · 2021 · Frontiers in Public Health